Urbain D, Reding P, Verdickt X, Ham H R
Nucl Med Commun. 1986 Jan;7(1):25-32. doi: 10.1097/00006231-198601000-00004.
Thallium-201 scintigraphy is an attractive method for studying the portal systemic shunting. However, the technique is sometimes hampered by a low rectal absorption. The present work shows that cirrhotic patients present a significantly lower activity in the regions of interest in relation to the low absorption of the tracer as compared with non-cirrhotic subjects (p less than 0.01). This study also demonstrates that the dilution of the tracer in a large volume cannot be envisaged in order to increase the surface contact and secondarily the absorption, because part of the tracer can reach the inferior vena cava via portal systemic communications in the lower part of the rectum. Oral administration of the thallium was also attempted but this route cannot be used in relation to its poor absorption and due to the difficulty in separating liver from intestinal activity. The study also shows that even in the case of low activity in the regions of interest, the interpretation of the test in cirrhotic patients is usually possible on the condition that the curves of radioactivity in the liver and cardiac areas are ascending. Using these criteria, only 6.7% of the tests were in fact not interpretable in this study.
铊-201闪烁扫描术是研究门体分流的一种有吸引力的方法。然而,该技术有时会因直肠吸收低而受到阻碍。目前的研究表明,与非肝硬化患者相比,肝硬化患者因示踪剂吸收低,其感兴趣区域的活性显著降低(p小于0.01)。本研究还表明,不能设想通过在大量液体中稀释示踪剂来增加表面接触并进而增加吸收,因为部分示踪剂可通过直肠下部的门体交通支到达下腔静脉。也曾尝试口服铊,但由于其吸收差以及难以区分肝脏和肠道的活性,该途径无法使用。研究还表明,即使感兴趣区域的活性较低,但只要肝脏和心脏区域的放射性曲线呈上升趋势,通常仍可对肝硬化患者的检查结果进行解读。根据这些标准,在本研究中实际上只有6.7%的检查结果无法解读。